selected publications
- Human cytomegalovirus gH/gL/gO binding to PDGFRα provides a regulatory signal activating the fusion protein gB that can be blocked by neutralizing antibodies. Journal of virology. 2025 Academic Article GET IT
- Human cytomegalovirus gH/gL/gO binding to PDGFRα provides a regulatory signal activating the fusion protein gB that can be blocked by neutralizing antibodies. 2025 GET IT
-
Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variants.
Immunity.
2023
Academic Article
GET IT
Times cited: 19 -
Single-cell analysis of memory B cells from top neutralizers reveals multiple sites of vulnerability within HCMV Trimer and Pentamer.
Immunity.
2023
Academic Article
GET IT
Times cited: 10 -
SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns.
Cell host & microbe.
2022
Academic Article
GET IT
Times cited: 59 -
No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adults.
iScience.
2022
Academic Article
GET IT
Times cited: 6 -
Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection.
Viruses.
2021
Academic Article
GET IT
Times cited: 45 -
Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19.
EMBO molecular medicine.
2021
Academic Article
GET IT
Times cited: 119 -
Effective high-throughput isolation of fully human antibodies targeting infectious pathogens.
Nature protocols.
2021
Review
GET IT
Times cited: 41 -
Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans.
Cell host & microbe.
2021
Academic Article
GET IT
Times cited: 117 -
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
2020
GET IT
Times cited: 47 -
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
Cell.
2020
Academic Article
GET IT
Times cited: 226